Suppr超能文献

通过第二位点抑制突变拯救常见p53癌症突变的机制。

Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations.

作者信息

Nikolova P V, Wong K B, DeDecker B, Henckel J, Fersht A R

机构信息

Cambridge University Chemical Laboratory and Cambridge Centre for Protein Engineering, MRC Centre, Hills Road, Cambridge CB2 2QH, UK.

出版信息

EMBO J. 2000 Feb 1;19(3):370-8. doi: 10.1093/emboj/19.3.370.

Abstract

The core domain of p53 is extremely susceptible to mutations that lead to loss of function. We analysed the stability and DNA-binding activity of such mutants to understand the mechanism of second-site suppressor mutations. Double-mutant cycles show that N239Y and N268D act as 'global stability' suppressors by increasing the stability of the cancer mutants G245S and V143A-the free energy changes are additive. Conversely, the suppressor H168R is specific for the R249S mutation: despite destabilizing wild type, H168R has virtually no effect on the stability of R249S, but restores its binding affinity for the gadd45 promoter. NMR structural comparisons of R249S/H168R and R249S/T123A/H168R with wild type and R249S show that H168R reverts some of the structural changes induced by R249S. These results have implications for possible drug therapy to restore the function of tumorigenic mutants of p53: the function of mutants such as V143A and G245S is theoretically possible to restore by small molecules that simply bind to and hence stabilize the native structure, whereas R249S requires alteration of its mutant native structure.

摘要

p53的核心结构域极易发生导致功能丧失的突变。我们分析了此类突变体的稳定性和DNA结合活性,以了解第二位点抑制突变的机制。双突变循环表明,N239Y和N268D通过增加癌症突变体G245S和V143A的稳定性而作为“全局稳定性”抑制子——自由能变化是累加的。相反,抑制子H168R对R249S突变具有特异性:尽管使野生型不稳定,但H168R对R249S的稳定性几乎没有影响,但能恢复其对gadd45启动子的结合亲和力。R249S/H168R和R249S/T123A/H168R与野生型和R249S的NMR结构比较表明,H168R逆转了R249S诱导的一些结构变化。这些结果对恢复p53致瘤突变体功能的可能药物治疗具有启示意义:理论上,通过简单结合并稳定天然结构的小分子有可能恢复V143A和G245S等突变体的功能,而R249S则需要改变其突变的天然结构。

相似文献

引用本文的文献

3
Navigating the complexity of p53-DNA binding: implications for cancer therapy.解析p53与DNA结合的复杂性:对癌症治疗的启示
Biophys Rev. 2024 Jul 11;16(4):479-496. doi: 10.1007/s12551-024-01207-4. eCollection 2024 Aug.
5
Translating p53-based therapies for cancer into the clinic.将基于 p53 的癌症疗法转化为临床应用。
Nat Rev Cancer. 2024 Mar;24(3):192-215. doi: 10.1038/s41568-023-00658-3. Epub 2024 Jan 29.
8
Small-molecule correctors and stabilizers to target p53.靶向 p53 的小分子矫正剂和稳定剂。
Trends Pharmacol Sci. 2023 May;44(5):274-289. doi: 10.1016/j.tips.2023.02.007. Epub 2023 Mar 22.

本文引用的文献

2
The p53 pathway.p53信号通路。
J Pathol. 1999 Jan;187(1):112-26. doi: 10.1002/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3.
8
Thermodynamic stability of wild-type and mutant p53 core domain.野生型和突变型p53核心结构域的热力学稳定性
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14338-42. doi: 10.1073/pnas.94.26.14338.
10
p53, the cellular gatekeeper for growth and division.p53,细胞生长和分裂的守门人。
Cell. 1997 Feb 7;88(3):323-31. doi: 10.1016/s0092-8674(00)81871-1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验